E N D
1. Anti-cholinergics & Steroids By Jim Clarke
2. Anticholinergic Bronchodilators Indications
Used for the treatment of bronchoconstriction in COPD
Is also available for the treatment of allergic rhinitis (nasal spray formulation)
3. How Anticholinergics Work
4. Vagal Triggers Irritant Aerosols
Cold dry air
Cigarette smoke
Noxious fumes
Histamines
High airflow (in exercise)
Persistent cough (upper airway inflammation)
5. Vagally-Mediated Bronchospasm
6. Anticholinergic Agents Ipratroprium Bromide (Atrovent)
Atropine Sulfate
Glycopyrrolate (Robinul)
Oxitroprium bromide*
7. Effects of Atrovent
8. Affects of Atropine
9. Available Forms & Characteristics
10. Anticholinergic Use in COPD Appear to work better than Beta agonists for patient with emphysema-chronic bronchitis
Also appears to be of some help in patients with severe long term asthma
Acts mainly on larger, more central airways
Has fewer side effects than beta agonists
11. Anticholinergic Use in Asthma Not as widely used for tx of asthma
Useful in tx of;
Nocturnal asthma
Psychogenic asthma
12. Combination Drugs New preparations mix albuterol and ipratroprium for maximum bronchdilation effect
Combivent (MDI)
Frequently - unit dose preparations of the above medications are given during the same nebulizer treatment
13. Advantages of Combivent Patients can receive the benefits of taking two drugs at once
Better bronchodilation with improved airflow
Compliance is better since there is only 1 MDI vs 2 separate MDI’s
14. Corticosteroids
15. Physiology of Corticosteroids Secreted by the Adrenal gland
“inner” zone or medulla produces epinephrine
“outer” zone or cortex produces corticosteroids
16. Products of Adrenal Cortex Mineral corticoids
aldosterone
Sex hormones
Estrogens & Androgens
Glucocorticoids
related to natural “cortisol”
Referred to as corticosteroids or “steroids”
17. General Action of Steroids Defined as “anti-inflammatory” agents used in the treatment and prevention of asthma and other conditions causing an exaggerated inflammatory response in the lung.
Inflammation is defined as “the response of vascularized tissue to injury”
18. Inflammation in Asthma New understanding of asthma defines it as a disease in which there is chronic inflammation of the airway wall, causing airflow limitation and hyperresponsiveness to a variety of stimuli
Process is “mediated” by a variety of agents
Mast cells; eosinophils; T lymphocytes; macrophages
19. Hallmark Signs of Inflammation Redness
Local dilation of blood vessels
Flare
Reddish color several centimeters around the original injury site
Wheal
Local swelling, occurring in minutes
20. Events at the Cellular Level Increased vascular permeability
Exudate in surrounding tissues
Leukocytic infiltration
White cells are attracted to area
Phagocytosis
White cells and macrophages ingest foreign material
21. Events at the Cellular Level Mediator Cascade
Histamine & other chemicals are released at injury site
Inflammatory mediators are produced
leukotrienes
22. Early Phase Response After initial triggering event, there is mast c cell degranulation with release of variety of chemical mediators (histamine; prostaglandin D2; leukotrine C4)
Early phase response is bronchospasm
There is a resulting decrease in expiratory flows from the lungs
23. Late Phase Response After 1-2 hours, mast cells mediators recruit eosinophils, basophils, etc. to the lung
After 6-8 hours, inflammatory cells have migrated into the airway walls
Mediators stimulate other vasoactive and bronchoactive agents that last up to 24 hours longer
Primary agent is arachidonic acid
24. Late Phase Culmination Increased mucus production
Increased permeability of vessels causing mucosal edema of the airway
Shedding of airway wall cells (desquamation)
Goblet cell hypertrophy
Thickening of epithelial basement membrane
25. Primary Actions of Steroids Inhibits recruitment & migration of inflammatory cells
Act by inhibiting the production of arachidonic acid
Induces gene expression for anti-inflammatory proteins and receptors
Suppresses gene expression for pro-inflammatory proteins
26. Other Steroidal Effects Improve responsiveness to Beta 2 agents
Decreases the white cell response to “chemotaxis”
This causes eosinophil counts to fall
27. Corticosterods for Oral Inhalation Dexamethasone (Decradron)
Beclomethasone (Vanceril; Beclovent)
Triamcinlone (Azmacort)
Flunisolide (AeroBid)
Fluticasone (Flovent)
Budesonide (not yet available in U.S.)
28. Side Effects Oral Candiasis or “Thrush”
Rinse mouth after use to prevent
Hoarseness
Cough and actual bronchoconstriction
Poor use leading to inadequate dosing
29. Systemic Steroids Given orally (p.o.); I.V. or I.M.
Oral forms reach peak action in as short as 1 hour
Some forms may remain available for up to 1-4 weeks (I.M. & I.V.)
30. Examples of Systemic Steroids Hydrocortisone (Solu-Cortef)
Methylprednisolone (Medrol; Solu-Medrol; Depo-Medrol)
Prednisolone (Delta-Cortef)
Dexamethasone (Decadron)
31. Side Effects of Systemic Steroids Hypothalmic-Pituitary-Adrenal Suppression
Immuno-suppression
Psychiatric reactions (psychosis)
Cataract formation
Osteoporosis
Fluid retention
Hypertension
32. More Side Effects! Peptic ulcer formation
Dermatologic changes
Thinning of skin
“Cushingoid” appearance
Retardation of growth (in children)
Slowing of healing in adults
Incrased glucose levels – steroids diabetes
Myopathy of skeletal muscle
33. Nasal Sprays Nasalide (flunisolide)
Beconase; Vancenase (beclomethasone)
Nasacort (triamcinolone)
Rhinocort (budesonide)
Flonase (fluticasone)
Doses are typically 1-2 sprays/nostril 1-4 times/day
34. Indications for Steroid Use Control of Asthma
It is NOT a rescue drug when given via MDI
Treatment of other bronchospastic conditions not controlled by other therapy
Control of seasonal allergic or non-allergic rhinitis
Steroids have been widely used in COPD
It is less clear if they actually help patients
35. End of Week 5 - Monday